control group:Methimazole and compound Xiaoying granule simulant

2 trials

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Conditions

Graves Disease

Phase 1

A randomized, double-blind, placebo-controlled study of Compound Xiaoying Granules in the treatment of Graves' disease with Yin deficiency and phlegm-heat syndrome

RecruitingChiCTR2100049078

Guang'anmen Hospital, China Academy of Chinese Medical SciencesGraves Disease

Start: 2021-07-26Updated: 2022-04-04

A randomized, double-blind, placebo-controlled study of Compound Xiaoying Granules in the treatment of Graves' disease with Yin deficiency and phlegm-heat syndrome

RecruitingITMCTR2100005094

Guang'anmen Hospital, China Academy of Chinese Medical SciencesGraves Disease

Start: 2021-07-26Updated: 2023-02-20